Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma

Failure to rescue as a source of variation in hospital mortality after hepatic surgery

(2014) G. Spolverato et al.   BRITISH JOURNAL OF SURGERY

Tumor Size Predicts Vascular Invasion and Histologic Grade Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma

(2014) Gaya Spolverato et al.   JOURNAL OF GASTROINTESTINAL SURGERY

A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma

(2014) Omar Hyder et al.   JAMA Surgery

Impact of complications on long-term survival after resection of colorectal liver metastases

(2013) M. N. Mavros et al.   BRITISH JOURNAL OF SURGERY

Recurrence after operative management of intrahepatic cholangiocarcinoma

(2013) Omar Hyder et al.   SURGERY

Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

(2011) Mechteld C. de Jong et al.   JOURNAL OF CLINICAL ONCOLOGY

Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion

(2011) Skye C. Mayo et al.   HPB

Effect of Postoperative Morbidity on Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

(2009) Hiromichi Ito et al.   ANNALS OF SURGERY

Intrahepatic Cholangiocarcinoma

(2009) Itaru Endo et al.   ANNALS OF SURGERY

Correlation Between Postoperative Infective Complications and Long-Term Outcomes After Hepatic Resection for Colorectal Liver Metastasis

(2009) Shahid G. Farid et al.   ANNALS OF SURGERY

Immune perturbations in patients along the perioperative period: Alterations in cell surface markers and leukocyte subtypes before and after surgery

(2009) Inbal Bartal et al.   BRAIN BEHAVIOR AND IMMUNITY

Liver Surgery for Colorectal Metastases: Results after 10 Years of Follow-Up. Long-Term Survivors, Late Recurrences, and Prognostic Role of Morbidity

(2008) Luca Viganò et al.   ANNALS OF SURGICAL ONCOLOGY

Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis

(2008) Marganit Benish et al.   ANNALS OF SURGICAL ONCOLOGY

Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans

(2008) Hashem B. El-Serag et al.   HEPATOLOGY

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma

(2008) S.A. Khan et al.   HPB